The tweet was deleted by the author.
But we saved everything 🙂.
Solid Biosciences announced that Chief Medical Officer Gabriel Brooks, M.D., will present at FierceBiotechWeek in Boston on Wednesday, May 13.
Brooks will address one of genetic medicine’s pressing challenges: achieving precise delivery of therapies where they are most needed. The session, scheduled from 10:10 to 10:35 am, will focus on innovative solutions and strategies being developed by the company. Brooks’s remarks are expected to draw attention from both industry peers and researchers seeking breakthroughs in targeted gene delivery.
Details about the specific methods or data to be shared have not been disclosed.
View post on X Loading...
Solid Biosciences recently presented new targeting strategies in precision gene therapy at a major symposium, highlighting its work in the field here. The company has also advanced its SGT-212 gene therapy for Friedreich ataxia into human trials, targeting neuromuscular and cardiac symptoms here. These developments mark a continued focus on improving targeted gene delivery.